Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Operating Margin (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Operating Margin for 6 consecutive years, with 9.47% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin fell 918.0% year-over-year to 9.47%, compared with a TTM value of 25.46% through Dec 2025, up 114.0%, and an annual FY2025 reading of 25.46%, up 114.0% over the prior year.
  • Operating Margin was 9.47% for Q4 2025 at Treace Medical Concepts, up from 31.22% in the prior quarter.
  • Across five years, Operating Margin topped out at 0.3% in Q4 2024 and bottomed at 48.1% in Q2 2024.
  • Average Operating Margin over 5 years is 26.08%, with a median of 30.38% recorded in 2023.
  • The sharpest move saw Operating Margin crashed -3182bps in 2021, then skyrocketed 1228bps in 2025.
  • Year by year, Operating Margin stood at 16.74% in 2021, then skyrocketed by 58bps to 7.03% in 2022, then crashed by -55bps to 10.9% in 2023, then surged by 97bps to 0.3% in 2024, then crashed by -3090bps to 9.47% in 2025.
  • Business Quant data shows Operating Margin for TMCI at 9.47% in Q4 2025, 31.22% in Q3 2025, and 35.82% in Q2 2025.